28th Annual North American Cystic Fibrosis Conference

W04: INF/MIC: Epidemiology & Management of Infection

Oct 9, 2014 10:00am ‐ Oct 9, 2014 11:45am

Standard: $49.99


This workshop will review the latest trends in respiratory microbiology based on US CF Registry data. This session will also focus on the long-term impact of successful Pseudomonas aeruginosa eradication on health outcomes and the chronic use of inhaled liposomal amikacin in the management of chronic Pseudomonas aeruginosa infection. The results of a large survey will also be presented examining antibiotic utilization to treat Mycobacterium abscessus infection. Lastly, the usefulness of biofilm antimicrobial susceptibility testing and microbiome analysis in the management of CF pulmonary exacerbations will be presented.


  • Bradley S. Quon, M.D., M.Sc, M.B.A., Clinical Research Fellow, University of British Columbia
  • Jane L. Burns, M.D., Professor, Pediatrics/Infectious Diseases, Univ. of Washington School of Medicine
  • Nicole Mayer Hamblett, Ph.D., Biostatistician, Children's Hospital & Regional Medical Center
  • Emily Knapp, Patient Registry Senior Coordinator, Cystic Fibrosis Foundation
  • Diana Bilton, M.D., FRCP, Consultant Physician & Honorary Senior Lecturer, Royal Brompton Hospital
  • Kelly A Holcomb, Pharm.D., Pharmacist, University Of Utah
  • Valerie Waters, M.D., M.Sc., Associate Professor

You must be logged in and own this session in order to post comments.